B. Kågedal

发表

Pharmacokinetics of N-acetylcysteine in man

L. Borgström, B. Kågedal, O. Paulsen, 2004, European Journal of Clinical Pharmacology.

Urinary excretion of amino acids in normal and cystinuric dogs.

B. Kågedal, J. Jeppsson, A. Hoppe, 1993, The British veterinary journal.

Determination of thyroxine-binding globulin in human serum by single radial immunodiffusion and radioimmunoassay.

B. Kågedal, M. Källberg, 1977, Clinical chemistry.

mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high‐risk disease when measured at diagnosis

I. Øra, B. Kågedal, P. Kogner, 2008, International journal of cancer.

Comparison of immunocytochemistry, real-time quantitative RT-PCR and flow cytometry for detection of minimal residual disease in neuroblastoma.

B. Kågedal, C. Rechnitzer, B. Petersen, 2005, International journal of oncology.

Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow.

B. Kågedal, P. Kogner, C. Träger, 2003, Clinical chemistry.

Early Identification of Permanent Myocardial Damage after Coronary Surgery is Aided by Repeated Measurements of CK-MB

H. Rutberg, E. Nylander, B. Kågedal, 2002, Scandinavian cardiovascular journal : SCJ.

Catecholamines and their metabolites.

D. Goldstein, B. Kågedal, Bertil K»gedal, 1988, Journal of chromatography.

Hydrophilic interaction liquid chromatographic analysis of aminohydroxyphenylalanines from melanin pigments.

B. Kågedal, D. Nezirević, K. Årstrand, 2007, Journal of chromatography. A.

Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells.

Carl-Fredrik Mandenius, Anders Lindahl, Peter Sartipy, 2010, Journal of biotechnology.

Long-term follow-up of ovarian cancer with monthly determinations of serum CA 125.

T. Högberg, B. Kågedal, 1992, Gynecologic oncology.

Assessment of renal function in workers previously exposed to cadmium.

B. Kågedal, O. Vesterberg, E. Lindberg, 1985, British journal of industrial medicine.

Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo

S. Eksborg, M. Henriksson, B. Kågedal, 2008, Oncogene.

Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells

A. Fyrberg, B. Kågedal, C. Peterson, 2011, Cancer Chemotherapy and Pharmacology.

Determination of creatinine in serum by high-performance liquid chromatography: a comparison of three ion-exchange methods.

B. Kågedal, B. Olsson, 1990, Journal of chromatography.

Insulin release and carbohydrate tolerance in hyperthyroid patients during non-selective or selective beta-1-adrenoceptor blockade.

B. Kågedal, O. Nilsson, L. Tegler, 1980, Acta endocrinologica.

Determination of a trivariate reference region for free thyroxine index, free triiodothyronine index, and thyrotropin from results obtained in a health survey of middle-aged women.

B. Kågedal, G. Tibbling, A. Sandström, 1978, Clinical chemistry.

Case Report: Subtherapeutic Vancomycin and Meropenem Concentrations due to Augmented Renal Clearance in a Patient With Intracranial Infection Caused by Streptococcus intermedius

B. Kågedal, A. Helldén, H. Hanberger, 2021, Frontiers in Pharmacology.

The effects of cimetidine (Tagamet) on renal function in patients with renal failure.

B. Kågedal, G. Bodemar, A. Walan, 2009, Acta medica Scandinavica.

Disialo-trisialo bridging of transferrin is due to increased branching and fucosylation of the carbohydrate moiety.

B. Kågedal, P. Påhlsson, E. Landberg, 2012, Clinica chimica acta; international journal of clinical chemistry.

Plasma cyanate concentrations in chronic renal failure.

B. Kågedal, R. Larsson, P. Lundquist, 1996, Clinical chemistry.

The effect of cimetidine, a new histamine H2-receptor antagonist, on renal function.

B. Kågedal, G. Bodemar, R. Larsson, 2009, Acta medica Scandinavica.

Effect of nicotinic-acid-induced variation of plasma free fatty acids on some hormones in starving subjects.

J. Thorell, B. Kågedal, S. Laurell, 1973, Scandinavian journal of clinical and laboratory investigation.

Cyanide detoxification in rats exposed to acetonitrile and fed a low protein diet.

B. Kågedal, H. Rosling, T. Tylleskär, 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Determination of L-3,4-dihydroxyphenylalanine in biological fluids and tissues.

B. Kågedal, N. Dizdar, A. Henriksson, 1991, Journal of chromatography.

TEDDY EPMD: A European Paediatric Medicines Database

K. Verhamme, M. Felisi, A. Ceci, 2009 .

Determination of S-sulfocysteine in urine by high-performance liquid chromatography.

B. Kågedal, B. Sörbo, M. Källberg, 1983, Journal of chromatography.

An Improved Method for Determination of Thiocyanate in Plasma and Urine

B. Kågedal, L. Nilsson, P. Lundquist, 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Comparison of N-acetylcysteine and l-2-oxothiazolidine-4-carboxylate as cysteine deliverers and glutathione precursors in human malignant melanoma transplants in mice

B. Kågedal, N. Dizdar, A. Kullman, 2000, Cancer Chemotherapy and Pharmacology.

SERUM FSH, LH AND OESTRONE LEVELS IN POSTMENOPAUSAL PATIENTS ON OESTROGEN THERAPY

L. Wallentin, B. Kågedal, U. Larsson‐cohn, 1978, British journal of obstetrics and gynaecology.

Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?

F. Bellanti, O. Della Pasqua, B. Kågedal, 2011, European Journal of Clinical Pharmacology.

The effect of variation of lipolysis after nicotinic acid and acetylsalicylate on blood concentrations of 3-hydroxybutyrate and acetoacetate in starving subjects.

B. Kågedal, G. Rooth, S. Laurell, 1970, Scandinavian journal of clinical and laboratory investigation.

Analysis of the cyanide metabolite 2-aminothiazoline-4-carboxylic acid in urine by high-performance liquid chromatography.

B. Kågedal, H. Rosling, P. Lundquist, 1995, Analytical biochemistry.

Are electrocardiographic Q-wave criteria reliable for diagnosis of perioperative myocardial infarction after coronary surgery?

H. Rutberg, C. Lundberg, E. Nylander, 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

No effect of oral N-acetylcysteine on the bioavailability of erythromycin and bacampicillin.

L. Borgström, B. Kågedal, O. Paulsen, 1988, The European respiratory journal.

Determination of transferrin without sample predilution by a turbidimetric assay on Boehringer Mannheim/Hitachi analysis Systems

D. Cottenceau, B. Kågedal, I. Domke, 1994 .

Dose dependent pharmacokinetics of N-acetylcysteine after oral dosing to man.

L. Borgström, B. Kågedal, 1990, Biopharmaceutics & drug disposition.

Quantitative relationships between pigment-related mRNA and biochemical melanoma markers in melanoma cell lines

B. Kågedal, K. Årstrand, M. Johansson, 2002, Melanoma research.

Unspecific elevation of plasma troponin‐T and CK‐MB after coronary surgery

H. Rutberg, E. Nylander, B. Kågedal, 2003, Scandinavian cardiovascular journal : SCJ.

HPLC analysis of pheomelanin degradation products in human urine.

K. Wakamatsu, S. Ito, B. Kågedal, 2003, Pigment cell research.

The value of cysteinyldopa in the follow-up of disseminated malignant melanoma

U. Ringborg, B. Kågedal, C. Lindholm, 2000, Melanoma research.

Automated high-performance liquid chromatographic determination of 5-S-cysteinyl-3,4-dihydroxyphenylalanine in urine.

B. Kågedal, C. Hansson, M. Källberg, 1989, Journal of chromatography.

Determination of 5-S-cysteinyldopa in human urine by direct injection in coupled-column high-performance liquid chromatography.

B. Kågedal, C. Hansson, M. Källberg, 1987, Journal of chromatography.

Liquid-chromatographic determination of 5-S-L-cysteinyl-L-dopa with electrochemical detection in urine prepurified with a phenylboronate affinity gel.

B. Kågedal, A. Pettersson, 1983, Clinical chemistry.

Effects of betamethasone on serum iodothyronines and thyroid hormone-binding proteins in Graves' disease.

G. Järnerot, B. Kågedal, L. Tegler, 2009, Acta medica Scandinavica.

Thyroid function after thermal trauma.

B. Kågedal, S. Smeds, S. Liljedahl, 1981, Scandinavian journal of plastic and reconstructive surgery.

Corticosteroids and thyroid function. Different effects on plasma volume, thyroid hormones and thyroid hormone-binding proteins after oral and intravenous administration.

G. Järnerot, B. Kågedal, B. Söderholm, 2009, Acta medica Scandinavica.

Corticotropin, Cortisol and β‐endorphin responses to the human corticotropin‐releasing hormone during melancholia and after unilateral electroconvulsive therapy

S. Stefansson, R. Ekman, B. Kågedal, 1990, Acta psychiatrica Scandinavica.

Effects of hip arthroplasty and peroperative dicloxacillin prophylaxis on renal function.

B. Kågedal, O. Wahlström, R. Larsson, 1992, Scandinavian journal of infectious diseases.

Effects of captopril on hepatic venous pressure and blood flow in patients with liver cirrhosis.

J. Wahren, L. Eriksson, B. Kågedal, 1984, The American journal of medicine.

CORTISOL, GROWTH HORMONE AND PROLACTIN RESPONSES TO INSULIN‐INDUCED HYPOGLYCAEMIA IN HYPERTHYROID PATIENTS BEFORE AND DURING β‐ADRENOCEPTOR BLOCKADE

B. Karlberg, B. Kågedal, B. Anderberg, 1980, Clinical endocrinology.

Vitamin A metabolism and mRNA expression of retinoid-binding protein and receptor genes in human epidermal melanocytes and melanoma cells

B. Kågedal, H. Törmä, E. Andersson, 1997, Melanoma research.

Correlation of DNA ploidy and S‐phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma

S. Aamdal, S. Wingren, J. Carstensen, 1996, International journal of cancer.

Codeine concentration in hair after oral administration is dependent on melanin content.

J. Ahlner, R. Kronstrand, G. Larson, 1999, Clinical chemistry.

Detecting minimal residual disease in neuroblastoma: still a ways to go.

B. Kågedal, 2009, Clinical chemistry.

Detecting MRD in Neuroblastoma: Still a Ways to Go

B. Kågedal, 2009 .

In situ microdialysis for monitoring of extracellular glutathione levels in normal, ischemic and post-ischemic skeletal muscle.

B. Kågedal, G. Nylander, A. Sirsjö, 1996, Free radical research.

Altered glutathione levels in ischemic and postischemic skeletal muscle: difference between severe and moderate ischemic insult.

B. Kågedal, G. Nylander, D. Lewis, 1996, The Journal of trauma.

Treatment of prostatic cancer by monthly injections of an LHRH-analogue depot.

B. Nordenskjöld, E. Varenhorst, B. Kågedal, 1988, Acta oncologica.

DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas.

S. Wingren, J. Carstensen, B. Kågedal, 1995, British Journal of Cancer.

Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma.

S. Wingren, X. Sun, J. Carstensen, 1996, European journal of cancer.

beta 2-Microglobulinuria among workers previously exposed to cadmium: follow-up and dose-response analyses.

B. Kågedal, O. Vesterberg, E. Lindberg, 1985, American journal of industrial medicine.

G. Greco, B. Kågedal, A. Napolitano, 2010, Clinica chimica acta; international journal of clinical chemistry.

Determination of eumelanin in human urine.

K. Wakamatsu, S. Ito, T. Kageshita, 2006, Pigment cell research.

Improved method for analysis of cysteinyldopa in human serum

B. Kågedal, A. Kullman, T. Rasmuson, 2004, Scandinavian journal of clinical and laboratory investigation.

S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5- methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma

L. Hansson, B. Kågedal, E. Schoultz, 1997, Melanoma research.

Lipoamidase and Biotinidase Activities in the Rat: Tissue Distribution and Intracellular Localization

B. Kågedal, L. Nilsson, 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Release of corticotropin after administration of corticotropin‐releasing hormone in depressed patients in relation to the dexamethasone suppression test

L. Wetterberg, B. Kågedal, B. Kjellman, 1993, Acta psychiatrica Scandinavica.

Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cells.

B. Kågedal, P. Kogner, C. Träger, 2004, Pigment cell research.

Reversed-phase ion-pair liquid chromatographic procedure with electrochemical detection for the analysis of urinary thiosulphate.

B. Kågedal, B. Sörbo, J. Mårtensson, 1983, Journal of chromatography.

Treatment of clinically normal and cystinuric dogs with 2-mercaptopropionylglycine.

B. Kågedal, A. Hoppe, T. Denneberg, 1988, American journal of veterinary research.

Canine cystinuria: an extended study on the effects of 2-mercaptopropionylglycine on cystine urolithiasis and urinary cystine excretion.

B. Kågedal, J. Jeppsson, A. Hoppe, 1993, The British veterinary journal.

UVB irradiation induces melanocyte increase in both exposed and shielded human skin.

B. Kågedal, U. Stierner, I. Rosdahl, 1989, The Journal of investigative dermatology.

Screening for thyroid disorders in middle-aged women by computer-assisted evaluation of a thyroid hormone panel.

J. Manson, B. Kågedal, B. Sörbo, 1981, Scandinavian journal of clinical and laboratory investigation.

High-performance liquid-chromatographic analysis of dopachrome and dihydroxyphenylalanine.

B. Kågedal, Y. Mishima, P. Konradsson, 1995, Analytical biochemistry.

Urinary excretion of 5-S-cysteinyldopa in relation to skin type, UVB-induced erythema, and melanocyte proliferation in human skin.

B. Kågedal, U. Stierner, I. Rosdahl, 1988, The Journal of investigative dermatology.

Gas chromatography-mass spectrometry analysis of pheomelanin degradation products.

B. Kågedal, Dženeta Nezirević Dernroth, Annica Rundström, 2009, Journal of chromatography. A.

Synthesis of 5-S-L-cysteinyl-glycine-L-dopa, a natural substrate for serum and melanocyte dipeptidase.

B. Kågedal, A. Pettersson, A. L. Gawelin, 1987, Analytical biochemistry.

Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in children.

B. Kågedal, A. Häger, I. Rosdahl, 1998, Acta dermato-venereologica.

The stability of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in human urine.

B. Kågedal, C. Hansson, K. Årstrand, 2008, Pigment cell research.

Determination of urinary 5-S-cysteinyldopa by high-performance liquid chromatography.

B. Kågedal, A. Pettersson, 1983, Journal of chromatography.

DNA ploidy and S-phase fraction in primary melanomas and their regional metastases

S. Wingren, J. Carstensen, B. Kågedal, 1994, Melanoma research.

L‐Dopa pharmacokinetics studied with microdialysis in patients with Parkinson's disease and a history of malignant melanoma

B. Kågedal, U. Hannestad, N. Dizdar, 1999, Acta neurologica Scandinavica.

An improved procedure for isolation of thyroxine-binding globulin from human pregnancy serum.

B. Kågedal, M. Källberg, 1977, Clinica chimica acta; international journal of clinical chemistry.

Non-selective and selective beta-1-adrenoceptor blocking agents in the treatment of hyperthyroidism.

B. Karlberg, B. Kågedal, O. Nilsson, 2009, Acta medica Scandinavica.

Differential vital staining of normal fibroblasts and melanoma cells by an anionic conjugated polyelectrolyte

K. Magnusson, K. Nilsson, Marek J. Łos, 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Nutritional assessment and clinical course in 112 elective surgical patients.

B. Kågedal, R. Sjödahl, B. Anderberg, 1983, Acta chirurgica Scandinavica.

Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets.

S. Eksborg, B. Gustavsson, B. Kågedal, 2008, Neuro-oncology.

Phosphatidylethanol Compared with Other Blood Tests as a Biomarker of Moderate Alcohol Consumption in Healthy Volunteers: A Prospective Randomized Study.

Anders Isaksson, Robert Kronstrand, Bertil Kågedal, 2015, Alcohol and alcoholism.

DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease.

S. Wingren, J. Carstensen, B. Kågedal, 1993, British Journal of Cancer.

Ppgalnac-t13: a New Molecular Marker of Bone Marrow Involvement in Neuroblastoma

P. Dessen, H. Ripoche, M. Barrois, 2006 .

Cysteinylglycine in urine determined by high-performance liquid chromatography

B. Kågedal, M. Källberg, 1998 .

Factors influencing the early plasma disappearance rate and liver uptake of thyroxine.

H. von Schenck, G. Järnerot, B. Kågedal, 1976, Upsala journal of medical sciences.

Serum free thyroid hormones are decreased by betamethasone treatment in Graves' disease.

B. Kågedal, L. Tegler, A. Gamstedt, 1988, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Fluorometric determination of cyanate in plasma by conversion to 2,4(1H,3H)-quinazolinedione and separation by high-performance liquid chromatography.

B. Kågedal, H. Rosling, P. Lundquist, 1993, Analytical Biochemistry.

Day-to-day variation in urinary excretion of the histamine metabolite methylimidazoleacetic acid

B. Kågedal, B. Lönnqvist, M. Källberg, 1998, Inflammation Research.

Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.

B. Karlberg, B. Kågedal, K. Tolagen, 1976, British medical journal.

Serum bile acid determination after different doses of orally ingested chenodeoxycholic acid. Evaluation of a simplified enzymatic method.

A. Frydén, B. Kågedal, U. Foberg, 1985, Scandinavian journal of gastroenterology.

Quantitative analysis of tyrosinase transcripts in blood.

B. Kågedal, K. Årstrand, M. Johansson, 2000, Clinical chemistry.

Nuclear morphometry: a strong prognostic factor for survival after secondary surgery in advanced ovarian cancer

T. Högberg, B. Kågedal, B. Risberg, 1991, International Journal of Gynecologic Cancer.

Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake.

B. Karlberg, B. Kågedal, R. Larsson, 1985, Journal of cardiovascular pharmacology.

Physiological cortisol substitution of long-term steroid-treated patients undergoing major surgery.

B. Karlberg, B. Kågedal, T. Symreng, 1981, British journal of anaesthesia.

How useful are housekeeping genes? Variable expression in melanoma metastases.

B. Kågedal, L. Hakansson, B. Gustafsson, 2007, Clinical chemistry and laboratory medicine.

Reversed-phase ion-pair high-performance liquid chromatography of mercaptoacetate and N-acetylcysteine after derivatization with N-(1-pyrene)maleimide and N-(7-dimethylamino-4-methyl-3-coumarinyl)maleimide.

B. Kågedal, M. Källberg, 1982, Journal of Chromatography A.

2-mercaptopropionate, a novel metabolite formed during treatment with 2-mercaptopropionyl-glycine in cystinuria

B. Kågedal, T. Denneberg, J. Mårtensson, 2004, European Journal of Clinical Pharmacology.

Sulphur amino‐acid degradation in subjects with hereditary glutathione synthetase deficiency (5‐oxoprolinuria)

A. Larsson, B. Kågedal, J. Mårtensson, 1985, European journal of clinical investigation.

Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid

B. Kågedal, A. Landtblom, M. Vrethem, 2003, Multiple sclerosis.

Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: quality assurance on behalf of SIOPEN-R-NET.

Ruth Ladenstein, A. Vicha, S. Burchill, 2007, European journal of cancer.

Early post-operative growth hormone levels predict the result of transsphenoidal tumour removal in acromegaly.

B. Karlberg, B. Kågedal, O. Nilsson, 1983, Acta endocrinologica.

Determination of non-protein-bound N-acetylcysteine in plasma by high-performance liquid chromatography.

B. Kågedal, J. Mårtensson, M. Källberg, 1984, Journal of chromatography.

Cysteinylglycine in urine determined by high-performance liquid chromatography.

B. Kågedal, M. Källberg, 1984, Journal of chromatography.

Failure of the PAXgene™ Blood RNA System to maintain mRNA stability in whole blood

B. Kågedal, C. Peterson, M. Lindqvist, 2005, Clinical chemistry and laboratory medicine.

Clinical value of total T4 and T3 determinations in patients with suspect hyperthyroidism before and after correction for binding proteins.

B. Kågedal, J. Ljunggren, G. Kallner, 2009, Acta medica Scandinavica.

Glomerular filtration rate is increased in burn patients.

B. Kågedal, R. Hahn, B. Lisander, 2010, Burns : journal of the International Society for Burn Injuries.

Electrodermal activity in relation to cortisol dysregulation in depressive patients

B. Kågedal, G. D'elia, L. Thorell, 1988, Acta psychiatrica Scandinavica.

CAP, HCS and urinary estriol measurements in risk pregnancies – A comparative study

G. Rydén, B. Kågedal, 1977, Journal of perinatal medicine.

A possible involvement of glutathione in the detoxication of sulfite.

B. Kågedal, B. Sörbo, M. Källberg, 1986, Biochemical and biophysical research communications.

Conjugated polythiophene probes target lysosome-related acidic vacuoles in cultured primary cells.

P. Björk, O. Inganäs, B. Kågedal, 2007, Molecular and cellular probes.

An imidazole functionalized pentameric thiophene displays different staining patterns in normal and malignant cells

K. Magnusson, K. Nilsson, M. Los, 2015, Front. Chem..

Influence of extradural blockade on serum thyroid hormone concentrations after surgery.

L. Jorfeldt, H. Rutberg, B. Kågedal, 1985, Acta chirurgica Scandinavica.

Pharmacokinetics and bioavailability of 2-mercaptopropionylglycine administered intravenously and orally in dogs.

B. Kågedal, A. Hoppe, T. Denneberg, 1991, Journal of Veterinary Pharmacology and Therapeutics.

High-performance liquid chromatography of 2-mercaptopropionylglycine and its metabolite 2-mercaptopropionic acid in plasma and urine after treatment with thiopronine.

B. Kågedal, A. Hoppe, T. Denneberg, 1987, Journal of chromatography.

Determination of 2-mercaptopropionylglycine in plasma and urine by high-performance liquid chromatography.

B. Kågedal, T. Denneberg, M. Carlsson, 1986, Journal of chromatography.

Treatment of Parkinson's disease with NADH

B. Kågedal, B. Lindvall, N. Dizdar, 1994, Acta neurologica Scandinavica.

Comparison of three bile acid provocation tests. Intravenous cholecystokinin, a standard test meal, and an oral bile acid load in healthy subjects.

A. Frydén, B. Kågedal, U. Foberg, 1987, Scandinavian journal of gastroenterology.

Evaluation of an oral bile acid loading test for assessment of liver function in chronic hepatitis. A comparison with fasting serum bile acids and i.v. galactose elimination test.

O. Weiland, A. Frydén, B. Kågedal, 2008, Liver.

Monitoring of troponin release from cardiomyocytes during exposure to toxic substances using surface plasmon resonance biosensing

C. Mandenius, B. Kågedal, Henrik Andersson, 2010, Analytical and bioanalytical chemistry.

Serum Half‐Life of the Tumor Marker CA 125 During Induction Chemotherapy as a Prognostic Indicator for Survival in Ovarian Carcinoma

B. Kågedal, Thomas Hoügberg, 1990, Acta obstetricia et gynecologica Scandinavica.

A high‐sensitivity fluorometric high‐performance liquid chromatographic method for determination of glutathione and other thiols in cultured melanoma cells, microdialysis samples from melanoma tissue, and blood plasma

B. Kågedal, N. Dizdar, S. Smeds, 1991, Melanoma research.

Grouping of patients with hyperparathyroidism by clinical signs, correlated to some biochemical findings.

J. Gillquist, B. Kågedal, L. Larsson, 1976, Acta chirurgica Scandinavica.

Human pharmacokinetics of L-3,4-dihydroxyphenylalanine studied with microdialysis.

B. Kågedal, N. Dizdar, B. Norlander, 1999, Clinical chemistry.

Urinary excretion of melanocyte metabolites during treatment with chloroquine phosphate.

B. Berne, B. Kågedal, C. Hansson, 1995, Acta Dermato-Venereologica.

Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.

B. Karlberg, B. Kågedal, B. Bergman, 1976, The American journal of cardiology.

Monitoring of troponin release from cardiomyocytes during exposure to toxic substances using surface plasmon resonance biosensing

C. Mandenius, B. Kågedal, Henrik Andersson, 2010, Analytical and bioanalytical chemistry.

Steady-State Pharmacokinetics of 2-Mercaptopropionylglycine (Tiopronin) in Healthy Volunteers and Patients with Cystinuria

B. Kågedal, T. Denneberg, M. Carlsson, 1994 .